MTOR and gastric cancer: Through bioinformatics and immunohistochemistry analysis, Liu et al. demonstrated that METTL14 could be a potential tumor suppressor in GC by regulating the PI3K/AKT/mTOR signaling pathway and epithelial mesenchymal transition (EMT) pathway.